InvestorsHub Logo
Followers 19
Posts 1991
Boards Moderated 0
Alias Born 02/25/2017

Re: None

Thursday, 04/13/2017 9:10:15 AM

Thursday, April 13, 2017 9:10:15 AM

Post# of 106837
Great article about our new FDA director...

Explains how too much regulation makes it difficult for newer innovative medicines to reach the market, crippling emerging biotechs. Deregulating the FDA would allow companies like us stem cell to withstand the expensive and arduous FDA approval process. RMAT is coming imo load up!

https://www.usatoday.com/story/opinion/2017/04/04/scott-gottlieb-fda-science-drugs-industry-campbell-berezow-column/100001336/